Overexpression of MCL-1 is recognized as having a critical role in several hematologic malignancies including diffuse large B-cell lymphoma (47), multiple myeloma (MM) (48), chronic lymphocytic lymphoma (49), and in AML cell survival and treatment resistance (50–52). The gene discussed is MCL1; the disease is acute myeloid leukemia.